Filed: 5/11/2023ACC: 0001104659-23-058987
📋 What this filing means
SOFINNOVA INVESTMENTS, INC. filed this quarterly 13F‑HR report disclosing 51 equity positions with a total reported market value of $1.56B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
51
Positions
$1.56B
Total AUM (reported)
75.02M
Total Shares
Allocation by class
COM$1.24B79.3%
SPONSORED ADR$86.22M5.5%
CL A$83.97M5.4%
TR UNIT$81.88M5.2%
SHS$66.23M4.2%
ORD SHS$3.01M0.2%
COMMON SHARES$2.30M0.1%
Portfolio Concentration
Top 3$583.74M37.3%
4–10$425.52M27.2%
11–25$375.16M24.0%
Rest$179.17M11.5%
Top 3 weight
37.3%
Top 10 weight
64.5%
Voting Authority Distribution
Total shares with voting rights: 75.02M
Sole
Full voting authority
75.02M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole51
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings51
Rows:
Karuna Therapeutics Inc
SOLEShares1.77M
TypeSH
Market value$322.07M
20.60%
Sole
1.77M
Shared
0.00
None
0.00
Natera Inc
SOLEShares3.10M
TypeSH
Market value$172.14M
11.01%
Sole
3.10M
Shared
0.00
None
0.00
Merck & Co Inc
SOLEShares841.52K
TypeSH
Market value$89.53M
5.73%
Sole
841.52K
Shared
0.00
None
0.00
SPDR S&P 500 ETF Trust
SOLEShares200K
TypeSH
Market value$81.88M
5.24%
Sole
200K
Shared
0.00
None
0.00
Ascendis Pharma A/S
SOLEShares754.03K
TypeSH
Market value$80.85M
5.17%
Sole
754.03K
Shared
0.00
None
0.00
Aerovate Therapeutics Inc
SOLEShares3.76M
TypeSH
Market value$75.81M
4.85%
Sole
3.76M
Shared
0.00
None
0.00
Reata Pharmaceuticals Inc
SOLEShares627.68K
TypeSH
Market value$57.07M
3.65%
Sole
627.68K
Shared
0.00
None
0.00
Eli Lilly and Co
SOLEShares137.10K
TypeSH
Market value$47.08M
3.01%
Sole
137.10K
Shared
0.00
None
0.00
Horizon Therapeutics PLC
SOLEShares408.82K
TypeSH
Market value$44.62M
2.85%
Sole
408.82K
Shared
0.00
None
0.00
Intuitive Surgical Inc
SOLEShares149.59K
TypeSH
Market value$38.22M
2.44%
Sole
149.59K
Shared
0.00
None
0.00
Biogen Inc
SOLEShares132.60K
TypeSH
Market value$36.87M
2.36%
Sole
132.60K
Shared
0.00
None
0.00
Biomarin Pharmaceutical Inc
SOLEShares359.04K
TypeSH
Market value$34.91M
2.23%
Sole
359.04K
Shared
0.00
None
0.00
Dexcom Inc
SOLEShares257.23K
TypeSH
Market value$29.88M
1.91%
Sole
257.23K
Shared
0.00
None
0.00
Travere Therapeutics Inc
SOLEShares1.26M
TypeSH
Market value$28.42M
1.82%
Sole
1.26M
Shared
0.00
None
0.00
Vera Therapeutics Inc
SOLEShares3.47M
TypeSH
Market value$26.91M
1.72%
Sole
3.47M
Shared
0.00
None
0.00
PTC Therapeutics Inc
SOLEShares517.10K
TypeSH
Market value$25.05M
1.60%
Sole
517.10K
Shared
0.00
None
0.00
Zentalis Pharmaceuticals Inc
SOLEShares1.44M
TypeSH
Market value$24.75M
1.58%
Sole
1.44M
Shared
0.00
None
0.00
Inhibrx Inc
SOLEShares1.24M
TypeSH
Market value$23.48M
1.50%
Sole
1.24M
Shared
0.00
None
0.00
Chinook Therapeutics Inc
SOLEShares1M
TypeSH
Market value$23.20M
1.48%
Sole
1M
Shared
0.00
None
0.00
Syndax Pharmaceuticals Inc
SOLEShares1.08M
TypeSH
Market value$22.71M
1.45%
Sole
1.08M
Shared
0.00
None
0.00
IVERIC bio Inc
SOLEShares905.98K
TypeSH
Market value$22.04M
1.41%
Sole
905.98K
Shared
0.00
None
0.00
Immatics NV
SOLEShares3.13M
TypeSH
Market value$21.62M
1.38%
Sole
3.13M
Shared
0.00
None
0.00
Inozyme Pharma Inc
SOLEShares3.66M
TypeSH
Market value$20.94M
1.34%
Sole
3.66M
Shared
0.00
None
0.00
Geron Corp
SOLEShares8.27M
TypeSH
Market value$17.96M
1.15%
Sole
8.27M
Shared
0.00
None
0.00
Sarepta Therapeutics Inc
SOLEShares119.06K
TypeSH
Market value$16.41M
1.05%
Sole
119.06K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Karuna Therapeutics IncSOLE | COM | 1.77M | SH | $322.07M 20.60% | 1.77M | 0.00 | 0.00 |
Natera IncSOLE | COM | 3.10M | SH | $172.14M 11.01% | 3.10M | 0.00 | 0.00 |
Merck & Co IncSOLE | COM | 841.52K | SH | $89.53M 5.73% | 841.52K | 0.00 | 0.00 |
SPDR S&P 500 ETF TrustSOLE | TR UNIT | 200K | SH | $81.88M 5.24% | 200K | 0.00 | 0.00 |
Ascendis Pharma A/SSOLE | SPONSORED ADR | 754.03K | SH | $80.85M 5.17% | 754.03K | 0.00 | 0.00 |
Aerovate Therapeutics IncSOLE | COM | 3.76M | SH | $75.81M 4.85% | 3.76M | 0.00 | 0.00 |
Reata Pharmaceuticals IncSOLE | CL A | 627.68K | SH | $57.07M 3.65% | 627.68K | 0.00 | 0.00 |
Eli Lilly and CoSOLE | COM | 137.10K | SH | $47.08M 3.01% | 137.10K | 0.00 | 0.00 |
Horizon Therapeutics PLCSOLE | SHS | 408.82K | SH | $44.62M 2.85% | 408.82K | 0.00 | 0.00 |
Intuitive Surgical IncSOLE | COM | 149.59K | SH | $38.22M 2.44% | 149.59K | 0.00 | 0.00 |
Biogen IncSOLE | COM | 132.60K | SH | $36.87M 2.36% | 132.60K | 0.00 | 0.00 |
Biomarin Pharmaceutical IncSOLE | COM | 359.04K | SH | $34.91M 2.23% | 359.04K | 0.00 | 0.00 |
Dexcom IncSOLE | COM | 257.23K | SH | $29.88M 1.91% | 257.23K | 0.00 | 0.00 |
Travere Therapeutics IncSOLE | COM | 1.26M | SH | $28.42M 1.82% | 1.26M | 0.00 | 0.00 |
Vera Therapeutics IncSOLE | CL A | 3.47M | SH | $26.91M 1.72% | 3.47M | 0.00 | 0.00 |
PTC Therapeutics IncSOLE | COM | 517.10K | SH | $25.05M 1.60% | 517.10K | 0.00 | 0.00 |
Zentalis Pharmaceuticals IncSOLE | COM | 1.44M | SH | $24.75M 1.58% | 1.44M | 0.00 | 0.00 |
Inhibrx IncSOLE | COM | 1.24M | SH | $23.48M 1.50% | 1.24M | 0.00 | 0.00 |
Chinook Therapeutics IncSOLE | COM | 1M | SH | $23.20M 1.48% | 1M | 0.00 | 0.00 |
Syndax Pharmaceuticals IncSOLE | COM | 1.08M | SH | $22.71M 1.45% | 1.08M | 0.00 | 0.00 |
IVERIC bio IncSOLE | COM | 905.98K | SH | $22.04M 1.41% | 905.98K | 0.00 | 0.00 |
Immatics NVSOLE | SHS | 3.13M | SH | $21.62M 1.38% | 3.13M | 0.00 | 0.00 |
Inozyme Pharma IncSOLE | COM | 3.66M | SH | $20.94M 1.34% | 3.66M | 0.00 | 0.00 |
Geron CorpSOLE | COM | 8.27M | SH | $17.96M 1.15% | 8.27M | 0.00 | 0.00 |
Sarepta Therapeutics IncSOLE | COM | 119.06K | SH | $16.41M 1.05% | 119.06K | 0.00 | 0.00 |
Page 1 of 3